| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 20, 2025 | Grant-Huerta Yanina Chief Accounting Officer | Sell | Atara Biotherapeutics, Inc. | ATRA | $6.76 | $15,000 | -5.65% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.